Neonatal Cord Blood Screening for HDN
NCT05617612 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2022-11-15
Summary
To evaluate the diagnostic efficiency of antibodies screening in cord blood for detection of HDN.
To help finding the antigen negative blood in a timely manner and reduce the morbidities and mortalities of HDN
Conditions
- HDN - Hemolytic Disease of the Newborn
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Day
- Max Age
- 3 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2023-12-01
- Completion
- 2024-01-01
More Related Trials
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Towards Routine HPA-screening In Pregnancy to Prevent FNAIT
NCT04067375 ·Status: COMPLETED
-
Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss
NCT03735108 ·Status: UNKNOWN
-
Doppler or Amniocentesis to Predict Fetal Anemia
NCT00295516 ·Status: COMPLETED ·Phase: PHASE3
-
Expanded NIPT for Pregnancy Complications
NCT04311749 ·Status: COMPLETED
-
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691 ·Status: TERMINATED ·Phase: NA
-
Cord Blood Preptin Levels in Infants
NCT06880003 ·Status: COMPLETED ·Phase: NA
-
A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood
NCT01472523 ·Status: COMPLETED
-
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
NCT06893926 ·Status: RECRUITING
-
Evaluation of a Patient Blood Management Protocol Impact on the Transfusion Rate in Delivery Hemorrhage
NCT06916832 ·Status: COMPLETED
-
The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage
NCT03591640 ·Status: COMPLETED ·Phase: NA
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers
NCT04431869 ·Status: COMPLETED
-
Screening for Hemoglobinopathies in Pregnant Women
NCT04029142 ·Status: COMPLETED
-
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
NCT00917007 ·Status: WITHDRAWN
-
Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane
NCT02104791 ·Status: UNKNOWN
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Maternal-fetal Immune Responses to Fetal Surgery
NCT04484441 ·Status: COMPLETED
-
Cardiac Functions as a New Method for Evaluation of Fetal Anemia Pre and Post Intrauterine Fetal Blood Transfusion
NCT03169907 ·Status: COMPLETED ·Phase: NA
-
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414 ·Status: RECRUITING
-
Fetal Cell Analysis From Maternal Blood
NCT05671744 ·Status: UNKNOWN ·Phase: NA
-
NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients
NCT04231591 ·Status: COMPLETED
-
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
NCT00456118 ·Status: COMPLETED
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED